- Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government for what reason some women with ovarian cancer are offered additional cycles of treatment prior to surgery, what assessment it has made of the impact of this approach on patient outcomes, and how any identified challenges are being addressed.
Answer
Decisions regarding the sequencing of ovarian cancer treatment, including whether surgery takes place before or after chemotherapy, are clinical matters for multidisciplinary teams within NHS Boards. These decisions are based on the individual circumstances of each patient and the available clinical evidence.
The Scottish Government does not direct individual treatment decisions. However, the Cancer Quality Performance Indicator programme supports monitoring of ovarian cancer services across Scotland and helps identify opportunities to improve the quality, consistency and outcomes of care.
- Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what action it is taking to ensure that women with ovarian cancer who are assessed as inoperable, or whose surgery is considered not to be possible within services in the West of Scotland, are able to access a second opinion and expertise, particularly when there are differing clinical opinions regarding whether surgery is appropriate.
Answer
Decisions regarding whether surgery is appropriate for women with ovarian cancer are clinical matters for multidisciplinary teams within NHS Boards, based on individual clinical circumstances and the available evidence.
The NHS Scotland Patient Charter makes clear that patients have the right to ask for a second opinion. NHS Boards are responsible for ensuring appropriate arrangements are in place to support access to further specialist advice where clinically appropriate.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Tuesday, 20 October 2026
-
Current Status:
Answered by Maree Todd on 16 November 2026
To ask the Scottish Government whether it will publish the report, NHS Scotland Service Evaluation
of Long COVID
Services, for 2025-26.
Answer
The NHS Scotland Service Evaluation of Long COVID Services 2025-26 was co-ordinated by the former National Services Scotland, now Public Services Delivery Scotland (PSD Scotland). The individual evaluations were undertaken and authored by participating boards, therefore Scottish Government is not responsible for the findings, conclusions or recommendations contained within the report.
PSD Scotland has agreed to publish the report. Work is currently underway to finalise branding and publication arrangements.
The intention is for the report to be published on the Right Decision Service website, and stakeholders will be notified once publication has taken place.
- Asked by: Murdo Fraser, MSP for Mid Scotland and Fife, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Gillian Martin on 16 November 2026
To ask the Scottish Government what capacity exists in the landfill sites operating in Scotland, and what plans there are to extend this capacity.
Answer
SEPA reports that as of 31 December 2025, the total remaining permitted capacity reported by operational landfill sites in Scotland was 16,215,667 tonnes across all landfill types.
It is important to note that this figure represents the remaining permitted capacity. It should not be interpreted as the amount of engineered landfill capacity currently available to accept waste, as SEPA do not hold information on the live engineered capacity available at individual sites. Landfill operators seeking to extend their permitted capacity would need to apply to their local authority and SEPA.
A breakdown by local authority can be found on SEPA’s website, here.
- Asked by: Craig Hoy, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Jenny Gilruth on 16 November 2026
To ask the Scottish Government how much it has spent on the development and delivery of its bond programme since 1 April 2026, broken down by (a) banking and bookrunner fees, (b) legal advice, (c) credit rating costs and (d) other external advice and costs.
Answer
Total external costs in 2025-26 relating to the Scottish Government Bond Programme, including associated credit rating activity, were £430,000, excluding VAT, set against an original budget allocation of £1 million for 2025-26.
The Scottish Government has a total programme budget of £2.1 million for 2026-27. Costs are forecast to remain within this budget. A detailed breakdown of costs cannot be provided as requested at this time due to commercial sensitivities.
- Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what action it is taking in response to the reported growing calls for interim access to Skyclarys for people living with Friedreich's ataxia.
Answer
As omaveloxolone (Skyclarys®) has been appraised by the Scottish Medicines Consortium (SMC), clinicians can use the Peer Approved Clinical System (PACS Tier Two) process to request the use of the medicine even though it is not routinely available on the NHS in Scotland. This is done on a ‘case-by-case’ basis for individuals living with Friedreich's ataxia, when the treating clinician considers that there would be significant clinical benefit.
Scottish Government officials have engaged with representatives from Biogen to understand if the company intends to resubmit omaveloxolone to the SMC. Biogen has provided assurance that it remains open to further commercial discussions, to support routine access to omaveloxolone in the NHS in Scotland.
- Asked by: Julie MacDougall, MSP for Mid Scotland and Fife, Reform UK
-
Date lodged: Monday, 02 November 2026
-
Current Status:
Answered by Alison Thewliss on 16 November 2026
To ask the Scottish Government what discussion it has had with industry experts and stakeholders in the social care sector regarding proposals to transfer responsibility for social care services from local authorities, including the potential impacts on staffing, funding and general operations of social care.
Answer
We are engaging with a wide range of partners as part of the ongoing three-month dialogue period committed to the in the Programme for Government 2026-31. On 20 October, the National Care Service Advisory Board met to discuss social care reform and throughout November, there are several roundtable meetings planned with stakeholders from across the social care sector. This is in addition to a wider programme of local government reform dialogue events which will include opportunities to discuss social care and allow for further evidence-gathering.
- Asked by: Duncan Dunlop, MSP for South Scotland, Scottish Liberal Democrats
-
Date lodged: Monday, 02 November 2026
-
Current Status:
Answered by Maree Todd on 16 November 2026
To ask the Scottish Government what plans it has reduce the number of children admitted to hospital with asthma attacks.
Answer
We are committed to reducing the number of children admitted to hospital with asthma attacks through prevention, early identification and timely access to appropriate care.
We continue to support children and young people with asthma through national guidance for schools, education authorities and NHS Boards, helping to ensure that pupils, parents, carers and school staff can recognise worsening symptoms and respond appropriately. Schools also have discretionary powers to hold spare salbutamol inhalers for use in emergencies when a pupil's own inhaler is unavailable.
Scotland's National Severe Asthma Pathway also supports earlier identification, specialist referral and improved access to treatment, helping to prevent avoidable hospital admissions.
- Asked by: Stephen Kerr, MSP for Mid Scotland and Fife, Scottish Conservative and Unionist Party
-
Date lodged: Thursday, 05 November 2026
-
Current Status:
Answered by Neil Gray on 16 November 2026
To ask the Scottish Government what assessment it has made of the impact on families of its decision not to continue funding the prison visitors centres at HMP Perth and HMP/YOI Polmont, in light of the findings in the Review of Prison Visitor Centres (PVCs) and Support Services.
Answer
I can confirm that the Scottish Government continues to fund Prison Visitor Centres (PVCs) at both HMP Perth and HMP & YOI Polmont.
Contrary to the premise of the question, there has been no decision to discontinue funding for PVCs at either establishment. Service provision has remained in place throughout, with full PVC services currently operating at both prisons.As there has been no decision to discontinue funding for PVCs at either establishment, no assessment has been made of the impact on families of such a decision.
Apex Scotland provides the PVC service at HMP & YOI Polmont, while CrossReach provides the PVC service at HMP Perth.
- Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what action it is taking to address reported concerns regarding decision-making in ovarian cancer care, including how treatment decisions are made, who is involved in those decisions, and how treatment recommendations are communicated to patients.
Answer
Decisions regarding ovarian cancer treatment are clinical matters for multidisciplinary teams within NHS Boards, based on a patient’s individual circumstances and the available clinical evidence. NHS Boards are responsible for ensuring patients are involved in decisions about their care and that treatment recommendations are communicated clearly.
The NHS Scotland Patient Charter makes clear that patients have the right to be informed about their care and treatment, be involved in decisions affecting them, and ask for a second opinion where appropriate.
The Scottish Government supports high quality and person-centred cancer care through implementation of the Cancer Strategy for Scotland 2023-2033 and associated action plans.